Immunohistochemistry and mass spectrometry for highly multiplexed cellular molecular imaging

Laboratory Investigation

Volumn 95, Issue 4, 2015, Pages 397-405

  Levenson, Richard M ^a   Borowsky, Alexander D ^a   Angelo, Michael ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; FORMALDEHYDE; HEMATOXYLIN; LANTHANIDE; PARAFFIN; TUMOR MARKER;

ANTIBODY LABELING; ARTICLE; AUTOFLUORESCENCE; BREAST CANCER; HUMAN; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MASS SPECTROMETRY; MOLECULAR IMAGING; PRIORITY JOURNAL; ANIMAL; CHEMISTRY; MOUSE; NEOPLASMS; PATHOLOGY; PROCEDURES;

ANIMALS; BIOMARKERS, TUMOR; HUMANS; IMMUNOHISTOCHEMISTRY; MASS SPECTROMETRY; MICE; MOLECULAR IMAGING; NEOPLASMS;

EID: 84926342669     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2015.2     Document Type: Article

References (44)

1. Simone NL, Bonner RF, Gillespie JW, et al. Laser-capture microdissection: opening the microscopic frontier to molecular analysis. Trends Genet 1998;14:272-276.
2. Lubieniecka JM, Nielsen TO. cDNA microarray-based translational research in soft tissue sarcoma. J Surg Oncol 2005;92:267-271.
3. Stack EC, Wang C, Roman KA, et al. Multiplexed immunohistochemistry, imaging, and quantitation: A review, with an assessment of Tyramide signal amplification, multispectral imaging and multiplex analysis. Methods 2014;70:46-58.
4. Rimm DL. What brown cannot do for you. Nat Biotechnol 2006;24:914-916.
5. Camp RL, Chung GG, Rimm DL. Automated subcellular localization and quantification of protein expression in tissue microarrays. Nat Med 2002;8:1323-1327.
6. Fountaine TJ, Wincovitch SM, Geho DH, et al. Multispectral imaging of clinically relevant cellular targets in tonsil and lymphoid tissue using semiconductor quantum dots. Mod Pathol 2006;19:1181-1191.
7. Bearman GH, Mahadevan-Jansen A, Levenson RM eds. Spectral Imaging: Instrumentation, Applications, and Analysis III, San Jose, CA, 2005.
8. Levenson R, Beechem J, McNamara G. Spectral imaging in preclinical research and clinical pathology. Anal Cell Pathol (Amst) 2012;35: 339-361.
9. Tsurui H, Nishimura H, Hattori S, et al. Seven-color fluorescence imaging of tissue samples based on Fourier spectroscopy and singular value decomposition. J Histochem Cytochem 2000;48:653-662.
10. Glass G, Papin JA, Mandell JW. SIMPLE: a sequential immunoperoxidase labeling and erasing method. J Histochem Cytochem 2009;57:899-905.
11. Wählby C, Erlandsson F, Bengtsson E, et al. Sequential immunofluorescence staining and image analysis for detection of large numbers of antigens in individual cell nuclei. Cytometry B Clin Cytom 2002;47:32-41.
12. Pirici D, Mogoanta L, Kumar-Singh S, et al. Antibody elution method for multiple immunohistochemistry on primary antibodies raised in the same species and of the same subtype. J Histochem Cytochem 2009, 57:567-575.
13. Friedenberger M, Bode M, Krusche A, et al. Fluorescence detection of protein clusters in individual cells and tissue sections by using toponome imaging system: sample preparation and measuring procedures. Nat Protoc 2007;2:2285-2294.
14. Schubert W, Bonnekoh B, Pommer AJ, et al. Analyzing proteome topology and function by automated multidimensional fluorescence microscopy. Nat Biotechnol 2006;24:1270-1278.
15. Schubert W, Gieseler A, Krusche A, et al. Toponome mapping in prostate cancer: detection of 2000 cell surface protein clusters in a single tissue section and cell type specific annotation by using a three symbol code. J Proteome Res 2009;8:2696-2707.
16. Zrazhevskiy P, Gao X. Quantum dot imaging platform for single-cell molecular profiling. Nat Commun 2013;4:1619.
17. Clarke GM, Zubovits JT, Shaikh KA, et al. A novel, automated technology for multiplex biomarker imaging and application to breast cancer. Histopathology 2014;64:242-255.
18. Zimak J, Schweller RM, Duose DY, et al. Programming in Situ Immunofluorescence Intensities through Interchangeable Reactions of Dynamic DNA Complexes. Chembiochem 2012;13:2722-2728.
19. Shcherbatyuk GV, Inman RH, Ghosh S. Anomalous photo-induced spectral changes in CdSe=ZnS quantum dots. J App Phys 2011;110: 053518-1-6.
20. Neher R, Neher E. Optimizing imaging parameters for the separation of multiple labels in a fluorescence image. J Microsc 2004;213:46-62.
21. Hollman-Hewgley D, Lazare M, Bordwell A, et al. A single slide multiplex assay for the evaluation of classical Hodgkin lymphoma. Am J Surg Pathol 2014;38:1193-1202.
22. Giesen C, Wang HA, Schapiro D, et al. Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry. Nat Methods 2014;11:417-422.
23. Angelo M, Bendall SC, Finck R, et al. Multiplexed ion beam imaging of human breast tumors. Nat Med 2014;20:436-442.
24. Blow N. Tissue preparation: Tissue issues. Nature 2007;448:959-963.
25. Rimm DL. Next-gen immunohistochemistry. Nat Methods 2014;11: 381-383.
26. Senyo SE, Steinhauser ML, Pizzimenti CL, et al. Mammalian heart renewal by pre-existing cardiomyocytes. Nature 2013;493:433-436.
27. Zhang D-S, Piazza V, Perrin BJ, et al. Multi-isotope imaging mass spectrometry reveals slow protein turnover in hair-cell stereocilia. Nature 2012;481:520-524.
28. Steinhauser ML, Bailey AP, Senyo SE, et al. Multi-isotope imaging mass spectrometry quantifies stem cell division and metabolism. Nature 2012;481:516-519.
29. Lechene C, Hillion F, McMahon G, et al. High-resolution quantitative imaging of mammalian and bacterial cells using stable isotope mass spectrometry. J Biol 2006;5:20.
30. Williams P. Biological imaging using secondary ions. J Biol 2006; 5:18.
31. Allred DC, Carlson RW, Berry DA, et al. NCCN task force report: estrogen receptor and progesterone receptor testing in breast cancer by immunohistochemistry. J Natl Compr Canc Netw 2009;7 (Suppl 6):S1-S21, quiz S2-3.
32. Wolff AC, Hammond ME, Schwartz JN, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 2007;25:118-145.
33. Luporsi E, Andre F, Spyratos F, et al. Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review. Breast Cancer Res Treat 2012;132:895-915.
34. Cuzick J, Dowsett M, Pineda S, et al. Prognostic value of a combined estrogen receptor, progesterone receptor, Ki-67, and human epidermal growth factor receptor 2 immunohistochemical score and comparison with the Genomic Health recurrence score in early breast cancer. J Clin Oncol 2011;29:4273-4278.
35. Afentakis M, Dowsett M, Sestak I, et al. Immunohistochemical BAG1 expression improves the estimation of residual risk by IHC4 in postmenopausal patients treated with anastrazole or tamoxifen: a TransATAC study. Breast Cancer Res Treat 2013;140:253-262.
36. Bartlett JM, Thomas J, Ross DT, et al. Mammostrat as a tool to stratify breast cancer patients at risk of recurrence during endocrine therapy. Breast Cancer Res 2010;12:R47.
37. Sung MT, Jiang Z, Montironi R, et al. Alpha-methylacyl-CoA racemase (P504S)/34betaE12/p63 triple cocktail stain in prostatic adenocarcinoma after hormonal therapy. Hum Pathol 2007;38:332-341.
38. Daoud NA, Li G, Evans AJ, et al. The value of triple antibody (34betaE12+p63+AMACR) cocktail stain in radical prostatectomy specimens with crushed surgical margins. J Clin Pathol 2012;65: 437-440.
39. Klein EA, Cooperberg MR, Magi-Galluzzi C, et al. A 17-gene Assay to Predict Prostate Cancer Aggressiveness in the Context of Gleason Grade Heterogeneity, Tumor Multifocality, and Biopsy Undersampling. Eur Urol 2014;66:550-560.
40. Qiu P, Simonds EF, Bendall SC, et al. Extracting a cellular hierarchy from high-dimensional cytometry data with SPADE. Nat Biotechnol 2011;29:886-891.
41. Shekhar K, Brodin P, Davis MM, et al. Automatic Classification of Cellular Expression by Nonlinear Stochastic Embedding (ACCENSE). Proc Natl Acad Sci USA 2014;111:202-207.
42. Chang AY, Bhattacharya N, Mu J, et al. Spatial organization of dendritic cells within tumor draining lymph nodes impacts clinical outcome in breast cancer patients. J Transl Med 2013;11:242.
43. Sovak MA, Bellas RE, Kim DW, et al. Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer. J Clin Invest 1997;100:2952-2960.
44. Planque N. Nuclear trafficking of secreted factors and cell-surface receptors: new pathways to regulate cell proliferation and differentiation, and involvement in cancers. Cell Commun Signal 2006;4:7.